Related Experiment Video
Updated: Sep 14, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Intravenous lidocaine: A transformative approach to reducing opioid use in pediatric burn patients in developing
Carolina Bonilla-González1, Juanita Uribe-Londoño1, Sergio Moreno-Lopez2
1Pediatric Intensive Care Unit and Burn Unit, Fundación Santa Fe de Bogotá, Colombia; The Burn Centre, Fundación Santa Fe de Bogotá, Colombia; Pediatrics Department Fundación Santa Fe de Bogotá, Colombia.
Insights
Intravenous lidocaine effectively reduced opioid use in pediatric burn patients following surgery. This analgesic approach demonstrated safety and efficacy, supporting its role in multimodal pain management strategies.
Area of Science:
- Pediatric Burn Care
- Pain Management
- Anesthesiology
Background:
- Effective postoperative pain control is critical for pediatric burn patient recovery.
- High opioid use in this population is associated with adverse effects and dependency risks.
- Intravenous lidocaine shows potential analgesic benefits but is understudied in pediatric burn patients.
Purpose of the Study:
- To evaluate the impact of continuous intravenous lidocaine infusion on opioid consumption in pediatric burn patients.
- To assess the safety profile and potential adverse events associated with lidocaine use in this cohort.
Main Methods:
- Retrospective cohort study of 126 pediatric burn patients.
- Comparison of opioid consumption (morphine equivalents) between patients who received lidocaine and those who did not.
- Analysis of demographic variables, burn characteristics, and clinical outcomes, including safety data.
Main Results:
- Patients receiving lidocaine (32.5%) had significantly lower opioid consumption compared to controls (0.07 vs. 0.21 morphine equivalents; p<0.05).
- Lidocaine was more frequently administered to patients with more severe burns (p<0.001).
- No adverse events or toxicity were observed with lidocaine infusion up to 1.5 mg/kg/h for 72 hours.
Conclusions:
- Continuous intravenous lidocaine infusion significantly reduces opioid requirements in pediatric burn patients.
- Lidocaine is a safe and effective component of multimodal pain management, contributing to opioid-sparing strategies.
- Further prospective trials are recommended to confirm the safety and efficacy of lidocaine in this patient population.
Background:
Effective postoperative pain control in pediatric burn patients is essential for recovery. Despite advances in pain management, opioid use remains high, contributing to adverse effects and risks of dependency. Intravenous (IV) lidocaine has shown analgesic benefits in adult and pediatric postsurgical contexts but remains underexplored in burned children. This study evaluates the impact of lidocaine on opioid consumption and its safety profile in this population.
Objective:
To determine whether continuous IV lidocaine infusion reduces opioid use in pediatric burn patients during the first 72 postoperative hours, and to assess its associated adverse events or toxicity.
Methods:
A retrospective cohort study was conducted in a pediatric burn unit, including 126 postoperative patients. Data were collected on opioid and lidocaine use, demographic variables, burn characteristics, and clinical outcomes. Opioid consumption, expressed in morphine equivalent doses, was compared between patients who received lidocaine and those who did not. Safety data were also analyzed.
Results:
Of the 126 patients, 48.4 % were female, with a median age of 36 months (IQR: 12-72). Burns were mostly due to boiling liquids (73.8 %) and were predominantly second-degree (38.9 %). Lidocaine was administered to 32.5 % of patients, mostly those with more severe burns (p < 0.001). Patients receiving lidocaine showed significantly lower opioid consumption (median: 0.07 vs. 0.21 morphine equivalents; p < 0.05). No adverse events or toxicity were observed in patients treated with lidocaine up to 1.5 mg/kg/h for 72 hours. Multivariable analysis confirmed the association between lidocaine use and reduced opioid dosage (β = -0.13, 95 % CI: -0.21; -0.05, p = 0.01).
Conclusions:
Intravenous lidocaine infusion significantly reduced opioid requirements in pediatric burn patients without causing adverse effects, supporting its use as part of a multimodal, opioid-sparing strategy. Further prospective trials are warranted to confirm its safety and efficacy.
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Parenteral Anesthetics: Overview
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Local Anesthetics: Clinical Application as Spinal Anesthesia

